The 2020 revision of the guidelines for the management of myeloproliferative neoplasms

In 2016, the World Health Organization revised the diagnostic criteria for myeloproliferative neoplasms (MPNs) based on the discovery of disease-driving genetic aberrations and extensive analysis of the clinical characteristics of patients with MPNs. Recent studies have suggested that additional som...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung-Yong, Bae, Sung Hwa, Bang, Soo-Mee, Eom, Ki-Seong, Hong, Junshik, Jang, Seongsoo, Jung, Chul Won, Kim, Hee-Jin, Kim, Ho Young, Kim, Min Kyoung, Kim, Soo-Jeong, Mun, Yeung-Chul, Nam, Seung-Hyun, Park, Jinny, Won, Jong-Ho, Choi, Chul Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820646/
https://www.ncbi.nlm.nih.gov/pubmed/33147902
http://dx.doi.org/10.3904/kjim.2020.319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820646/
https://www.ncbi.nlm.nih.gov/pubmed/33147902
http://dx.doi.org/10.3904/kjim.2020.319

Ejemplares similares